INAB

0.75801.86%
PC

Peter C. Brandt

Independent Director

Mr. Peter C. Brandt has been an Independent Director at IN8bio, Inc (former Incysus Therapeutics, Inc)since July 2019. He was Independent Chairman of Rexahn Pharmaceuticals, Inc. since June 2015 until November 2020. He served as Director of Rexahn Pharmaceuticals, Inc. since September 2010 until November 2020. He served as an Interim Chief Executive Officer and Interim President at Epocrates Inc. from November 16, 2011 to March 27, 2012. Mr. Brandt served as the President and Chief Executive Officer of Noven Pharmaceuticals Inc. from April 2008 to August 2009. He has extensive business and industry experience. He spent 28 years at Pfizer. He served as President - U.S. Pharmaceuticals Operations at Pfizer Inc., where he helped deliver revenue and earnings growth while engineering major change within Pfizer's U.S. pharmaceuticals organization. He served as a Director at Ocuphire Pharma, Inc. since November 5, 2020. He led the Latin American Pharmaceuticals Operations, as well as the following Pfizer Worldwide Pharmaceuticals functions: Senior Vice President of Finance, Information Technology, Planning and Business Development and Pfizer Health Solutions. He served as an Executive Vice President of US Pharmaceuticals, a subsidiary of Pfizer Inc. since February 2006. He oversaw the operations of Pfizer's care management subsidiary, Pfizer Healthcare Solutions. He served as the Chairman of Amicore, Inc. Mr. Brandt served as Chairman of the Board of Epocrates, Inc. until March 12, 2013 and served as its Vice Chairman since March 27, 2012. He serves as a Trustee of The Population Council, Inc. He served as a Director of Auxilium Pharmaceuticals Inc. from December 20, 2010 to January 29, 2015. Mr. Brandt served as a Director of Epocrates, Inc. from February 2011 to March 12, 2013. He served as a Director at Noven Pharmaceuticals Inc. from April 2008 to late 2009. He served as a Director of Amicore, Inc. Mr. Brandt holds an MBA in Finance and Accounting from Columbia School of Business and his BA in economics and marketing from the University of Connecticut.

Positions